FDA NDA · NDA220583
ISOVUE READI
Sponsor: BRACCO
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
NDA220583
TYPE
NDA
ORIGINAL APPROVAL
2026-10-09
LATEST ACTION
2026-10-09
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
ISOVUE READIPrescription
IOPAMIDOL 300MG · SOLUTION · ORAL
ISOVUE READIPrescription
IOPAMIDOL 200MG · SOLUTION · ORAL
ISOVUE READIPrescription
IOPAMIDOL 370MG · SOLUTION · ORAL
ISOVUE READIPrescription
IOPAMIDOL 250MG · SOLUTION · ORAL
Approval history
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →